Literature DB >> 24448144

Psoriasiform reactions during treatment with abatacept.

Elena Conde-Montero1, Ofelia Baniandrés-Rodríguez, María Dolores Mendoza-Cembranos, Celia Horcajada-Reales, Ricardo Suárez-Fernández.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24448144     DOI： 10.4103/0378-6323.125502

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  4 in total

Review 1.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

Review 2.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

3.  Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling.

Authors:  Kayo Tanita; Taku Fujimura; Aya Kakizaki; Sadanori Furudate; Yoshiyuki Kusakari; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2015-07-24

4.  New onset or worsening of psoriasis following biologic therapy: A case series.

Authors:  Vincenzo Bruzzese; Vincenzo De Francesco; Cesare Hassan; Roberto Lorenzetti; Palma Scolieri; Cinzia Marrese; Angelo Zullo
Journal:  Int J Immunopathol Pharmacol       Date:  2017-01-30       Impact factor: 3.219
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.